| Mr Richard R Reynolds, MD | |
|
2301 Holmes St, Kansas City, MO 64108-2640 | |
| (816) 404-4100 | |
| Not Available |
| Full Name | Mr Richard R Reynolds |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 2301 Holmes St, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679540405 | NPI | - | NPPES |
| 203392808 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 101360 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Truman Medical Center Hospital Hill | Kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health Physicians | 1153235825 | 301 |
News Archive
Seemingly dead cells perform a surprising task in the lens of a fish eye. Every morning and evening they change the lens's capacity to refract light in order to enhance color perception during the day and night vision when it's dark. This is shown in new research from Lund University in Sweden.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
Researchers at the Semel Institute for Neuroscience and Human Behavior at UCLA have found that a social skills program for high-functioning young adults with autism spectrum disorder significantly improved the participants' ability to engage with their peers.
Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria.
To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.
› Verified 2 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Seemingly dead cells perform a surprising task in the lens of a fish eye. Every morning and evening they change the lens's capacity to refract light in order to enhance color perception during the day and night vision when it's dark. This is shown in new research from Lund University in Sweden.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
Researchers at the Semel Institute for Neuroscience and Human Behavior at UCLA have found that a social skills program for high-functioning young adults with autism spectrum disorder significantly improved the participants' ability to engage with their peers.
Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria.
To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.
› Verified 2 days ago
| Entity Name | University Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669456257 PECOS PAC ID: 1153235825 Enrollment ID: O20031117000701 |
News Archive
Seemingly dead cells perform a surprising task in the lens of a fish eye. Every morning and evening they change the lens's capacity to refract light in order to enhance color perception during the day and night vision when it's dark. This is shown in new research from Lund University in Sweden.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
Researchers at the Semel Institute for Neuroscience and Human Behavior at UCLA have found that a social skills program for high-functioning young adults with autism spectrum disorder significantly improved the participants' ability to engage with their peers.
Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria.
To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Richard R Reynolds, MD 2310 Holmes St, Ste 800, Kansas City, MO 64108-2634 Ph: (816) 218-2500 | Mr Richard R Reynolds, MD 2301 Holmes St, Kansas City, MO 64108-2640 Ph: (816) 404-4100 |
News Archive
Seemingly dead cells perform a surprising task in the lens of a fish eye. Every morning and evening they change the lens's capacity to refract light in order to enhance color perception during the day and night vision when it's dark. This is shown in new research from Lund University in Sweden.
ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258.
Researchers at the Semel Institute for Neuroscience and Human Behavior at UCLA have found that a social skills program for high-functioning young adults with autism spectrum disorder significantly improved the participants' ability to engage with their peers.
Experts are calling for a global review of guidelines used to diagnose sepsis, after a study found one in eight patients with infections severe enough to need admission to an Intensive Care Unit in Australia and New Zealand, did not meet current criteria.
To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.
› Verified 2 days ago
Susan Marie Mou, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2101 Charlotte St, Kansas City, MO 64108 Phone: 816-404-7820 Fax: 816-404-8159 | |
Dr. Kristopher Shawn Lybarger, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Bldg 2, Ste 546, Kansas City, MO 64132 Phone: 816-926-0777 Fax: 816-926-0707 | |
Ronald Edward Brunnabend Ii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2340 E Meyer Blvd Ste 598, Kansas City, MO 64132 Phone: 816-444-6888 | |
Douglas R Perryman, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4400 Broadway Ste 302, Kansas City, MO 64111 Phone: 816-931-9344 Fax: 816-931-4168 | |
Anupama Kotha, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-3584 Fax: 816-932-5873 | |
Zachary James Alholm, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-0880 | |
Gerald Lee Miller Jr., MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 6400 Prospect, #598, Kansas City, MO 64132 Phone: 816-444-6888 Fax: 816-444-1375 |